Role of AHR in the Development of the Liver and Blood Vessels

The AH Receptor in Biology and Toxicology

Volumn , Issue , 2011, Pages 413-421

  Ichihara, Sahoko ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

AHR, in liver, blood vessels; AHR, ischemia induced angiogenesis; Liver phenotype, mice and AHR

Indexed keywords

EID: 84877755896     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118140574.ch29     Document Type: Chapter

References (60)

1. Swanson, H. I. and Bradfield, C. A. (1993). The AH-receptor: genetics, structure and function. Pharmacogenetics, 3, 213-230.
2. Dolwick, K. M., Schmidt, J. V., Carver, L. A., Swanson, H. I., and Bradfield, C. A. (1993). Cloning and expression of a human Ah receptor cDNA. Molecular Pharmacology, 44, 911-917.
3. Hayashi, S., Watanabe, J., Nakachi, K., Eguchi, H., Gotoh, O., and Kawajiri, K. (1994). Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis, 15, 801-806.
4. Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., and Bradfield, C. A. (1996). Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proceedings of the National Academy of Sciences of the United States of America, 93, 6731-6736.
5. Fernandez-Salguero, P. M., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S., Kimura, S., Nebert, D.W., Rudikoff, S.,Ward, J. M., and Gonzalez, F. J. (1995). Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science, 268, 722-726.
6. Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T. N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., and Fujii-Kuriyama, Y. (1997). Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes to Cells, 2, 645-654.
7. Fernandez-Salguero, P. M., Ward, J. M., Sundberg, J. P., and Gonzalez, F. J. (1997). Lesions of aryl-hydrocarbon receptordeficient mice. Veterinary Pathology, 34, 605-614.
8. Lahvis, G. P., Lindell, S. L., Thomas, R. S., McCuskey, R. S., Murphy, C., Glover, E., Bentz, M., Southard, J., and Bradfield, C. A. (2000). Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 97, 10442-10447.
9. Dubuisson, L., Bioulac-Sage, P., Bedin, C., and Balabaud, C. (1984). Hepatocyte ultrastructure in the rat after long term portacaval anastomosis: a morphometric study. Journal of Submicroscopical Cytology, 16, 283-287.
10. Schroder, R.,Muller, O., and Bircher, J. (1985). The portacaval and splenocaval shunt in the normal rat. A morphometric and functional reevaluation. Journal of Hepatology, 1, 107-123.
11. Lahvis, G. P., Pyzalski, R. W., Glover, E., Pitot, H. C., McElwee, M. K., and Bradfield, C. A. (2005). The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Molecular Pharmacology, 67, 714-720.
12. Harstad, E. B., Guite, C. A., Thomae, T. L., and Bradfield, C. A. (2006). Liver deformation in Ahr-null mice: evidence for aberrant hepatic perfusion in early development. Molecular Pharmacology, 69, 1534-1541.
13. Ko,M. K., Chi, J. G., and Chang, B. L. (1985). Hyaloid vascular pattern in the human fetus. Journal of Pediatric Ophthalmology & Strabismus, 22, 188-193.
14. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., and Schulte-Hermann, R. (1992). Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor b1. Proceedings of the National Academy of Sciences of the United States of America, 89, 5408-5412.
15. Bernasconi, P., Torchiana, E., Confalonieri, P., Brugnoni, R., Barresi, R., Mora, M., Correlio, F., Morandi, L., and Mantegazza, R. (1995). Expression of transforming growth factor-b1 in dystrophic patient muscle correlates with fibrosis. Journal of Clinical Investigation, 96, 1137-1144.
16. Sanderson, N., Factor, V., Nagy, P., Kopp, J., Kondaiah, P., Wakefield, L., Roberts, A. B., Sporn, M. B., and Thorgeirsson, S. S. (1995). Hepatic expression of mature transforming growth factor b1 in transgenic mice results in multiple tissue lesions. Proceedings of the National Academy of Sciences of the United States of America, 92, 2572-2576.
17. Zaher, H., Fernandez-Salguero, P. M., Letterio, J., Sheikh, M. S., Fornace, A. J., Jr., Roberts, A. B., and Gonzalez, F. J. (1998). The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-b and apoptosis. Molecular Pharmacology, 54, 313-321.
18. -/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Research, 57, 2835-2838.
19. Andreola, F., Calvisi, D. F., Elizondo, G., Jakowlew, S. B., Mariano, J., Gonzalez, F. J., and De Luca, L.-M. (2004). Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletion. Hepatology, 39, 157-166.
20. Bunger,M. K., Moran, S. M., Glover, E., Thomae, T. L., Lahvis, G. P., Lin, B. C., and Bradfield, C. A. (2003). Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. Journal of Biological Chemistry, 278, 17767-17774.
21. Walisser, J. A., Bunger, M. K., Glover, E., and Bradfield, C. A. (2004). Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development. Proceedings of the National Academy of Sciences of the United States of America, 101, 16677-16682.
22. Walisser, J. A., Bunger, M. K., Glover, E., Harstad, E. B., and Bradfield, C. A. (2004). Patent ductus venosus and dioxin resistance in mice harboring a hypomorphic Arnt allele. Journal of Biological Chemistry, 279, 16326-16331.
23. Walissern, J. A., Glover, E., Pande, K., Liss, A. L., and Bradfield, C. A. (2005). Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types. Proceedings of the National Academy of Sciences of the United States of America, 102, 17858-17863.
24. Fukunaga, B. N., Probst, M. R., Reisz-Porszasz, S., and Hankinson, O. (1995). Identification of functional domains of the aryl hydrocarbon receptor. Journal of Biological Chemistry, 270, 29270-29278.
25. Ge, N. L. and Elferink, C. J. (1998). A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle. Journal of Biological Chemistry, 273, 22708-22713.
26. Puga, A., Barnes, S. J., Dalton, T. P., Chang, C., Knudsen, E. S., and Maier, M. A. (2000). Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. Journal of Biological Chemistry, 275, 2943-2950.
27. Bunger,M. K., Glover, E., Moran, S. M.,Walisser, J. A., Lahvis, G. P., Hsu, E. L., and Bradfield, C. A. (2008). Abnormal liver development and resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in mice carrying a mutation in the DNA-binding domain of the aryl hydrocarbon receptor. Toxicological Sciences, 106, 83-92.
28. Frueh, F.W., Hayashibara, K. C., Brown, P. O., and Whitlock, J. P., Jr (2001). Use of cDNA microarrays to analyze dioxininduced changes in human liver gene expression. Toxicology Letters, 6, 189-203.
29. Zeytun, A., McKallip, R. J., Fisher, M., Camacho, I., Nagarkatti, M., and Nagarkatti, P. S. (2002). Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arrays. Toxicology, 178, 241-260.
30. Fletcher, N., Wahlstrom, D., Lundberg, R., Nilsson, C. B., Nilsson, K. C., Stockling, K., Hellmold, H., and Håkansson, H. (2005). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. Toxicology and Applied Pharmacology, 207, 1-24.
31. Kurachi, M., Hashimoto, S., Obata, A., Nagai, S., Nagahata, T., Inadera, H., Sone, H., Tohyama, C., Kaneko, S., Kobayashi, K., and Matsushima, K. (2002). Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive genes in mouse liver by serial analysis of gene expression. Biochemical and Biophysical Research Communications, 292, 368-377.
32. -/-) mice. Journal of Veterinary Medical Science, 68, 663-668.
33. Boverhof, D. R., Burgoon, L. D., Tashiro, C., Sharratt, B., Chittim, B., Harkema, J. R., Mendrick, D. L., and Zacharewski, T. R. (2006). Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicological Sciences, 94, 398-416.
34. Boutros, P. C., Yan, R., Moffat, I. D., Pohjanvirta, R., and Okey, A. B. (2008). Transcriptomic responses to 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat and mouse. BMC Genomics, 9, 419-435.
35. Tijet, N., Boutros, P. C., Moffat, I. D., Okey,A. B., Tuomisto, J., and Pohjanvirta, R. (2006). Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Molecular Pharmacology, 69, 140-153.
36. Boutros, P. C., Bielefeld, K. A., Pohjanvirta, R., and Harper, P. A. (2009). Dioxin-dependent and dioxin-independent gene batteries: comparison of liver and kidney in AHR-null mice. Toxicological Sciences, 112, 245-256.
37. Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nature Medicine, 6, 389-395.
38. Ferrara, N., Houck, K., Jakeman, L., and Leung, D.W. (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Reviews, 13, 18-32.
39. Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L.-Q., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M. (1994). Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. Journal of Clinical Investigation, 93, 662-670.
40. Forsythe, J. A., Jiang, B. H., Iyer,N.V., Agani, F., Leung, S.W., Koos, R. D., and Semenza, G. L. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology, 16, 4604-4613.
41. 2 tension. Proceedings of the National Academy of Sciences of the United States of America, 92, 5510-5514.
42. Reyes, H., Reisz-Porszansz, S., and Hankinson, O. (1992). Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science, 256, 1193-1195.
43. Ichihara, S., Yamada Y, Ichihara G, Nakajima T, and Murahara T. (2007). A role of the aryl hydrocarbon receptor in regulation of ischemia-induced angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 1297-1304.
44. Thackaberry, E. A., Smith, S. M., Gabaldno, D. M., andWalker, M. K. (2002). Aryl hydrocarbon receptor null mice develop cardiac hypertrophy and increased hypoxia-inducible factor-1a in the absence of cardiac hypoxia. Cardiovascular Toxicology, 2, 263-273.
45. Fritz, W. A., Lin, T. M., Cardiff, R. D., and Peterson, R. E. (2007). The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice. Carcinogenesis, 28, 497-505.
46. Fritz, W. A., Lin, T. M., and Peterson, R. E. (2008). The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates. Carcinogenesis, 29, 1077-1082.
47. Schmidt, J. V. and Bradfield, C. A. (1996). Ah receptor signaling pathways. Annual Review of Cell and Developmental Biology, 12, 55-89.
48. Ichihara, S., Yamada, Y., Gonzalez, F. J., Nakajima, T., Murohara, T., and Ichihara, G. (2009). Inhibition of ischemia-induced angiogenesis by benzo[a]pyrene in a manner dependent on the aryl hydrocarbon receptor. Biochemical and Biophysical Research Communications, 381, 44-49.
49. Michaud, S.-É ., Ménard, C., Guy, L.-G., Gennaro, G., and Rivard, A. (2003). Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: impairment of the HIF-1a/VEGF pathway. FASEB Journal, 17, 1150-1152.
50. Ivnitski-Steele, I. D., Sanchez, A., and Walker, M. K. (2004). 2,3,7,8-Tetrachlorodibenzo-p-dioxin reduces myocardial hypoxia and vascular endothelial growth factor expression during chick embryo development. Birth Defects Research, Part A, 70, 51-58.
51. Ivnitski-Steele, I. D., Friggens, M., Chavez, M., andWalker,M. K. (2005). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary vasculogenesis is mediated, in part, by reduced responsiveness to endogenous angiogenic stimuli, including vascular endothelial growth factor A (VEGF-A). Birth Defects Research, Part A, 73, 440-446.
52. Juan, S. H., Lee, J. L., Ho, P. Y., Lee, Y. H., and Lee, W. S. (2006). Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells. European Journal of Pharmacology, 530, 1-8.
53. Hankinson, O. (2005). Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Archives of Biochemistry and Biophysics, 433, 379-386.
54. Pollenz, R. S., Davarinos, N. A., and Shearer, T. P. (1999). Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription. Molecular Pharmacology, 56, 1127-1137.
55. Wormke, M., Stoner, M., Saville, B., and Safe, S. (2000). Crosstalk between estrogen receptor a and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes. FEBS Letters, 478, 109-112.
56. Ishimura, R., Ohsako, S., Kawakami, T., Sakaue, M., Aoki, Y., and Tohyama, C. (2002). Altered protein profile and possible hypoxia in the placenta of 2,3,7,8-tetrachlorodibenzo-p-dioxinexposed rats. Toxicology and Applied Pharmacology, 185, 197-206.
57. Mizutani, T.,Yoshino, M., Satake, T., Nakagawa, M., Ishimura, R., Tohyama, C., Kokame, K., Kangawa, K., and Miyamoto, K. (2004). Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible and -suppressive genes in the rat placenta: induction of interferon-regulated genes with possible inhibitory roles for angiogenesis in the placenta. Endocrine Journal, 51, 69-77.
58. Ishimura, R., Kawakami, T., Ohsako, S., Nohara, K., and Tohyama, C. (2006). Suppressive effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vascular remodeling that takes place in the normal labyrinth zone of rat placenta during late gestation. Toxicological Sciences, 91, 265-274.
59. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., and Simon, M. C. (1997). Abnormal angiogenesis and response to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature, 386, 403-407.
60. Dabir, P., Marinic, T. E., Krukovets, I., and Stenina, O. I. (2008). Aryl hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells. Circulation Research, 102, 1558-1565.